These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2474882)

  • 21. [Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog].
    Fuse H; Akimoto S; Akakura K; Shimazaki J; Murakami S
    Hinyokika Kiyo; 1988 Mar; 34(3):555-60. PubMed ID: 3133936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of luteinizing hormone-releasing hormone antagonist cetrorelix in the treatment of symptomatic benign prostatic hyperplasia.
    Comaru-Schally AM; Brannan W; Schally AV; Colcolough M; Monga M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3826-31. PubMed ID: 9814453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LHRH agonists. A nonsurgical treatment for benign prostatic hyperplasia.
    Oesterling JE
    J Androl; 1991; 12(6):381-8. PubMed ID: 1722794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of a powerful luteinizing hormone releasing hormone analogue agonist and estrogen in the treatment of advanced prostatic cancer.
    Winfield H; Trachtenberg J
    J Urol; 1984 Jun; 131(6):1107-9. PubMed ID: 6427477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early results of LH-RH agonist treatment with or without chlormadinone acetate for hormone therapy of naive localized or locally advanced prostate cancer: a prospective and randomized study. The Prostate Cancer Study Group.
    Akaza H; Homma Y; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Ohashi Y; Aso Y
    Jpn J Clin Oncol; 2000 Mar; 30(3):131-6. PubMed ID: 10798540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [LH-RH agonists as therapeutic alternative in patients with benign prostatic hyperplasia (BPH) and surgical contraindication. Long term follow up].
    Granados Loarca EA; Chéchile Toniolo G; Villavicencio Mavrich H
    Arch Esp Urol; 1996 Nov; 49(9):923-7. PubMed ID: 9133292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute urinary retention secondary to benign prostatic hyperplasia. Effect of alpha-adrenergic blockade.
    Goodwin MI; Chester JF; Jenkins JD
    Urol Int; 1986; 41(6):430-1. PubMed ID: 2435043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Large benign prostatic hiperplasia].
    Soria-Fernández GR; Jungfermann-Guzman JR; Lomelín-Ramos JP; Jaspersen-Gastelum J; Rosas-Nava JE
    Cir Cir; 2012; 80(6):543-5. PubMed ID: 23336149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Suzuki T; Otsuka A; Ozono S
    Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
    Santen RJ; Warner B
    Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteinizing hormone-releasing hormone (LH-RH) analogs in treatment of prostatic cancer. Clinical perspective.
    Smith JA
    Urology; 1986 Jan; 27(1 Suppl):9-15. PubMed ID: 3079936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
    Gerber GS; Jahoda A; Bales GT; Albala DM
    Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benign prostatic hyperplasia. Practical treatment guidelines.
    Tammela T
    Drugs Aging; 1997 May; 10(5):349-66. PubMed ID: 9143856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical treatment of prostatic obstruction. An objective assessment.
    Claridge M
    Invest Urol; 1975 Mar; 12(5):401-4. PubMed ID: 46221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical efficacy of (D-Leu6)-des Gly-NH2(10)-LHRH ethylamide against prostatic cancer].
    Yamanaka H; Makino T; Kumasaka F; Shida K
    Hinyokika Kiyo; 1984 Apr; 30(4):545-60. PubMed ID: 6435416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term suppression of luteinizing hormone, follicle-stimulating hormone and testosterone by daily administration of leuprolide.
    Glode LM; Smith JA
    J Urol; 1987 Jan; 137(1):57-60. PubMed ID: 3098990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR].
    Niijima T; Aso Y; Akaza H; Fujita K; Fuse H; Hosaka M; Isurugi K; Kamidono S; Katayama T; Kawabe K
    Hinyokika Kiyo; 1990 Nov; 36(11):1343-60. PubMed ID: 2126912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benign prostatic hyperplasia treated by castration or the LH-RH analogue buserelin: a report on 6 cases.
    Schroeder FH; Westerhof M; Bosch RJ; Kurth KH
    Eur Urol; 1986; 12(5):318-21. PubMed ID: 2430808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: the case for monitoring serum testosterone and a treatment decision algorithm.
    Oefelein MG; Cornum R
    J Urol; 2000 Sep; 164(3 Pt 1):726-9. PubMed ID: 10953134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.